X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.globenewswire.com/news-release/2021/08/23/2284853/20739/en/Ultragenyx-Announces-Approval-of-Dojolvi-triheptanoin-in-Brazil-for-the-Treatment-of-Long-chain-Fatty-Acid-Oxidation-Disorders-in-Adults-and-Children.html
https://ir.ultragenyx.com/news-releases/news-release-details/ultragenyx-announces-approval-dojolvitm-ux007triheptanoin-canada
https://www.globenewswire.com/news-release/2020/07/22/2065806/0/en/Ultragenyx-Announces-U-S-Commercial-Launch-of-Dojolvi-triheptanoin-the-First-FDA-Approved-Therapy-for-the-Treatment-of-Long-chain-Fatty-Acid-Oxidation-Disorders.html
https://www.prnewswire.com/news-releases/orsini-pharmaceutical-services-expands-partnership-with-ultragenyx-to-provide-dojolvi-triheptanoin---for-patients-with-long-chain-fatty-acid-oxidation-disorders-lc-faod-301091602.html
https://pharmaphorum.com/news/fda-backs-ultragenyxs-second-rare-disease-drug-in-the-space-of-a-fortnight/
https://www.prnewswire.com/news-releases/pantherx-rare-pharmacy-selected-by-ultragenyx-pharmaceutical-to-distribute-dojolvi-triheptanoin-for-patients-with-long-chain-fatty-acid-oxidation-disorders-lc-faod-301087880.html
https://www.raps.org/news-and-articles/news-articles/2020/7/fda-approvals-roundup-fintepla-dojolvi-phesgo
http://ir.ultragenyx.com/news-releases/news-release-details/ultragenyx-announces-us-fda-approval-dojolvitm-ux007triheptanoin
https://seekingalpha.com/news/3505469-fda-accepts-ultragenyxs-triheptanoin-nda-rare-oxidation-disorders
https://www.investors.com/news/technology/ultragenyx-stock-rises-rare-disease-drug/
Market Place
Share 
